Competitive problems in the drug industry: hearings before Subcommittee on Monopoly and Anticompetitive Activities of the Select Committee on Small Business, United States Senate, Ninety-first Congress, first session ... |
From inside the book
Results 1-5 of 75
Page 11638
... discuss its content , they were unfamiliar with the substance of the letter and in some instances denied any knowledge of it . Some claimed that it was an original letter , written by them , and were crest fallen to find that their ...
... discuss its content , they were unfamiliar with the substance of the letter and in some instances denied any knowledge of it . Some claimed that it was an original letter , written by them , and were crest fallen to find that their ...
Page 11654
... discuss the effect of MAC on state antisubstitution laws ? Secretary WEINBERGER . I do not think it has any effect on the State laws . We have not occupied the field so fully as to preclude any State action . And I do not know that it ...
... discuss the effect of MAC on state antisubstitution laws ? Secretary WEINBERGER . I do not think it has any effect on the State laws . We have not occupied the field so fully as to preclude any State action . And I do not know that it ...
Page 11657
... discussed today since the MAC list is essen- tially a list of interchangeable drug products . And I would have to reach the same conclusion today that I did then - namely , that I see no danger of therapeutic inequivalence if the list ...
... discussed today since the MAC list is essen- tially a list of interchangeable drug products . And I would have to reach the same conclusion today that I did then - namely , that I see no danger of therapeutic inequivalence if the list ...
Page 11665
... are several details with which we are not satisfied and which are critical as to our ability to support the resultant program . Before discussing specifics of the proposed program , we feel COMPETITIVE PROBLEMS IN THE DRUG INDUSTRY 11665.
... are several details with which we are not satisfied and which are critical as to our ability to support the resultant program . Before discussing specifics of the proposed program , we feel COMPETITIVE PROBLEMS IN THE DRUG INDUSTRY 11665.
Page 11666
... discussing specifics of the proposed program , we feel com- pelled to mention that it is most distressing to us that HEW has permitted the controversy over the MAC program to ferment for what is now over a year since the policy was ...
... discussing specifics of the proposed program , we feel com- pelled to mention that it is most distressing to us that HEW has permitted the controversy over the MAC program to ferment for what is now over a year since the policy was ...
Other editions - View all
Common terms and phrases
actual acquisition cost agencies antisubstitution laws APhA average wholesale price bioavailability bioequivalence brand name central CHAIRMAN competitive Defense develop Digoxin dispensing Drug Administration drug product Drug Research Board effective erythromycin established Food and Drug formulary Gaylord Nelson GORDON Government Government-wide hospital implementation inspection Interagency Labs local purchases MAC price MAC program MAC regulations Manufacturing Practices Maximum Allowable Cost Medicaid MEDICAL AND NONPERISHABLE medical items Medicare meeting ment MICHELOTTI patient percent Pharmaceutical pharmacists pharmacy physician PITTMAN prednisone prescribed present problems procurement professional proposed regulations purchasing quality assurance quality assurance program recommendations reimbursement resolution responsibility savings SCHMIDT Secretary WEINBERGER selection Small Business Sorett specific standards statement STETLER subcommittee substitution laws Supply Management Committee Tablets task group therapeutic equivalence tion TRYGSTAD WHITWORTH
Popular passages
Page 12087 - Since many agencies, including the Food and Drug Administration in the Department of Health, Education and Welfare, in which the appellant was employed, have nothing to do with national security, the Act of 1950 has nothing to do with them. The authorization to bring "other...
Page 12159 - Register, to be In the public interest in connection with the performance of duties imposed on that agency by law.
Page 11700 - I AM PLEASED TO BE HERE TODAY AND TO HAVE THE OPPORTUNITY TO ASK QUESTIONS OF SECRETARY JACKSON.
Page 12328 - Engineering before the Subcommittee on Health of the Senate Committee on Labor and Public Welfare, 94th Cong., 1st Sess.
Page 12055 - The hearing need not be conducted according to technical rules relating to evidence and witnesses. Any relevant evidence shall be admitted if it is the sort of evidence on which responsible persons are accustomed to rely in the conduct of serious affairs, regardless of the existence of any common law or statutory rule which might make improper the admission of such evidence over objection in civil actions.
Page 11663 - OF THE SELECT COMMITTEE ON SMALL BUSINESS, Washington, DC The subcommittee met, pursuant to notice, at 10 am, in room 2221.
Page 11925 - Action is pleased to have the opportunity to present its views on the $12.7 billion supplemental appropriation for America's efforts in Vietnam.
Page 11732 - STATEMENT OF ALEXANDER M. SCHMIDT, MD, COMMISSIONER, FOOD AND DRUG ADMINISTRATION; ACCOMPANIED BY J. RICHARD GROUT, MD, DIRECTOR, BUREAU OF DRUGS; PETER BARTON »HUTT, ASSISTANT GENERAL COUNSEL; LLOYD B. TEPPER, MD, ASSOCIATE COMMISSIONER FOR SCIENCE; BARRETT SCOVILLE, MD, ACTING DIRECTOR OF THE DIVISION OF BUREAU OF NEUROt PHARMACOLOGICAL PROJECTS; AND ROBERT WETHERELL, DIRECTOR, OFFICE OF LEGISLATIVE SERVICES Dr.
Page 12055 - substantial evidence" means : Evidence consisting of adequate and well controlled investigations, including clinical investigations by experts qualified by scientific training and experience to evaluate the effectiveness of the drug involved, on the basis of which it could fairly and responsibly be concluded by such experts that the drug will have the effect it purports or is represented to have under the conditions of use prescribed, recommended, or suggested in the labeling...
Page 12054 - The means employed shall be such as to allow, to the extent practicable, eligible persons to secure health care in the same manner employed by the public generally, and without discrimination or segregation based purely on their economic disability.